Evaluate Safety of ComBe Five (Liquid) in Healthy Vietnamese Children Aged From 8 - 10 Weeks as a 3-dose Series, Interval for Each Dose is 4 Weeks

NCT02904213 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
330
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products

Collaborators